AIM： TO observe the therapeutic effects of new traditional Chinese medicine （TClVl） therapy on coagulation disorder and accompanying intractable jaundice in HBV-related liver cirrhosis patients. METHODS： Using str...AIM： TO observe the therapeutic effects of new traditional Chinese medicine （TClVl） therapy on coagulation disorder and accompanying intractable jaundice in HBV-related liver cirrhosis patients. METHODS： Using stratified random sampling according to fibrinogen （Fib） levels, 145 liver cirrhosis patients due to hepatitis B complicated by coagulation disorder were treated. Of them, 70 in research group were treated with TCM by ＂nourishing yin, cooling blood and invigorating blood circulation＂ and Western medicine, 75 in control group were treated with conventional Western medicine. The indexes of liver function, coagulation function and bleeding events were observed and compared. RESULTS： The prothrombin time （PT） was shorter and the fibrinogen （Fib） level was higher in the research group than in the control group （Fib = 1.6-2.0 g/L, 1.1-1.5 g/L, and ≤ 1.0 g/L）. The total bilirubin （TBIL） level was significantly lower in the research group than in the control group, except for the subgroup of FIB ≤ 1.0 g/L. CONCLUSION： TCM therapy can improve coagulation fuction and decrease TBIL.展开更多
目的探讨益气升阳活血法指导中药方剂对伴随2型糖尿病(diabetes mellitus type 2,T2DM)牙周炎的疗效。方法选择2019年7月—2021年3月医院收治的110例伴随T2DM的牙周炎患者进行研究,采用随机双盲法将其分为研究组和对照组,每组55例,两组...目的探讨益气升阳活血法指导中药方剂对伴随2型糖尿病(diabetes mellitus type 2,T2DM)牙周炎的疗效。方法选择2019年7月—2021年3月医院收治的110例伴随T2DM的牙周炎患者进行研究,采用随机双盲法将其分为研究组和对照组,每组55例,两组均接受牙周基础治疗,研究组在基础治疗的同时,给予益气升阳活血中药治疗,两组治疗时间均为1个月,比较两组患者治疗前后牙周指数包括牙周探测位点的平均探诊深度(probing depth,PD)、临床附着水平(clinical attachment level,CAL)、探诊出血指数(bleeding on probing,BOP),糖化血红蛋白(glycatedhemoglobinA1c,HbA1c)与超敏C反应蛋白(High sensitivity C-reactive protein,hsCRP),以及两组治疗前后血糖平均水平。结果治疗后两组各项牙周指数均低于本组治疗前(P<0.05),其中研究组PD、CAL和BOP水平均低于对照组(P<0.05),治疗后两组HbA1c、hsCRP均低于本组治疗前(P<0.05),其中研究组低于对照组(P<0.05),治疗后两组空腹血糖均较本组治疗前降低(P<0.05),研究组低于对照组(P<0.05)。结论益气升阳活血法指导中药方剂对伴随T2DM的牙周炎患者效果显著,显著改善患者牙周指数及血糖水平,适合推广应用。展开更多
基金Science and Technology Agency of Guangdong Province,NO.2008B030301041
文摘AIM： TO observe the therapeutic effects of new traditional Chinese medicine （TClVl） therapy on coagulation disorder and accompanying intractable jaundice in HBV-related liver cirrhosis patients. METHODS： Using stratified random sampling according to fibrinogen （Fib） levels, 145 liver cirrhosis patients due to hepatitis B complicated by coagulation disorder were treated. Of them, 70 in research group were treated with TCM by ＂nourishing yin, cooling blood and invigorating blood circulation＂ and Western medicine, 75 in control group were treated with conventional Western medicine. The indexes of liver function, coagulation function and bleeding events were observed and compared. RESULTS： The prothrombin time （PT） was shorter and the fibrinogen （Fib） level was higher in the research group than in the control group （Fib = 1.6-2.0 g/L, 1.1-1.5 g/L, and ≤ 1.0 g/L）. The total bilirubin （TBIL） level was significantly lower in the research group than in the control group, except for the subgroup of FIB ≤ 1.0 g/L. CONCLUSION： TCM therapy can improve coagulation fuction and decrease TBIL.
